Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Tuberkuloz Ve Toraks|June 13, 2024
Investigation of age and smoking in NSCLC patients with uncommon EGFR mutationsYosuke Maezawa, Manato Taguchi, Takeshi Kawakami, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter StudyTakashi Hatori, Takeshi Numata, Toshihiro Shiozawa, et al.
Anticancer Research|March 27, 2024
Patient Age and EGFR-positive Non-small Cell Lung Cancer: A Multicenter Retrospective StudyYosuke Maezawa, Manato Taguchi, Takeshi Kawakami, et al.
Contemporary Oncology (Poznan, Poland)|May 7, 2025
Age and smoking intensity in non-small cell lung cancer patients with the anaplastic lymphoma kinase fusion geneYosuke Maezawa, Manato Taguchi, Takeshi Kawakami, et al.
Internal Medicine (Tokyo, Japan)|February 22, 2021
Negative-pressure pulmonary Hemorrhaging Due to Severe Obstructive Sleep ApneaKenya Kuramoto, Masashi Matsuyama, Mizu Nonaka, et al.
Cancer Diagnosis & Prognosis|January 6, 2025
Outcomes of Combined Atezolizumab Plus Chemotherapy in Non-small Cell Lung Cancer Patients in Clinical PracticeTakeshi Numata, Ryota Nakamura, Toshihiro Shiozawa, et al.
Anticancer Research|May 31, 2024
Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung CancerSatoshi Ano, Norihiro Kikuchi, Shinichiro Okauchi, et al.
Thoracic Cancer|November 28, 2023
Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study)Ou Yamaguchi, Keita Mori, Saori Takata, et al.
Anticancer Research|September 29, 2023
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)Tomohiro Tamura, Takeshi Numata, Hidetoshi Yanai, et al.
In Vivo (Athens, Greece)|August 31, 2023
Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI)Shinichiro Okauchi, Gen Ohara, Toshihiro Shiozawa, et al.
Pageof 7